Pennsylvania Convention Center, Room 115-B
Sponsored by the ASIP Breast Cancer Scientific Interest Group
Chair
Dennis Jones, PhD
Boston University
Co-Chair
Bethany Hannafon, PhD
University of Oklahoma
| Chair - Welcome and Introductions | ||
| 8:30 AM - 9:05 AM | Activating Mutations in HER2 Confer Resistance to Therapy in Breast Cancer Utthara Nayar, PhD • Johns Hopkins Bloomberg School of Public Health |
 |
| 9:05 AM - 9:40 AM | Tumor-Fibroblast Crosstalk Mediates Resistance to HER2-Targeted Therapies in HER2+ Breast Cancer Ioannis Zervantonakis, PhD • University Pittsburgh |
 |
| 9:40 AM - 10:15 AM | Pathways Regulating the Survival and Recurrence of Residual Cancer Cells James V. Alvarez, PhD • Fred Hutchinson Cancer Research Center |
 |
| 10:15 - 10:50 AM |
Heterogeneity of MHC-I and MHC-II Antigen Presentation in Immunotherapy Outcomes in Breast Cancer |
 |
| Questions and Answers |